Streettalk Advisors »

Karyopharm Therapeutics shares owned by Streettalk Advisors

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Streettalk Advisors from 13F filings

Historical chart of Streettalk Advisors investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Streettalk Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Streettalk Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.4k 10k 0.83

More positions owned by Streettalk Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr Mbs Etf (MBB)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Noble Corp Ord Shs A (NE)
Apple (AAPL)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Total Usd (IUSB)

View all positions for Streettalk Advisors

Top funds holding Karyopharm Therapeutics

Vanguard Group
Palo Alto Investors
BlackRock
BlackRock
Citadel Advisors
Goldman Sachs Group
Marshall Wace
Avidity Partners Management
Bnp Paribas Arbitrage, Snc
GSA Capital Partners
CAM Group Holding A/S
Jpmorgan Chase & Co
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Renaissance Technologies

View all funds holding Karyopharm Therapeutics